XR Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,600
Closed -$242K 440
2022
Q4
$242K Buy
+2,600
New +$251K 0.02% 417
2021
Q4
Sell
-10,900
Closed -$22K 465
2021
Q3
$22K Buy
+10,900
New +$913K 0.01% 333
2021
Q1
Sell
-12,100
Closed -$46K 489
2020
Q4
$46K Buy
+12,100
New +$787K ﹤0.01% 306
2020
Q1
Sell
-23,200
Closed -$4K 225
2019
Q4
$4K Buy
23,200
+1,600
+7% +$112K ﹤0.01% 218
2019
Q3
$7K Sell
21,600
-3,500
-14% -$207K ﹤0.01% 212
2019
Q2
$31K Sell
25,100
-1,000
-4% -$53.9K 0.01% 197
2019
Q1
$72K Sell
26,100
-27,400
-51% -$1.69M 0.01% 186
2018
Q4
$57K Buy
+53,500
New +$3.99M 0.02% 200
2018
Q3
Sell
-10,200
Closed -$113K 403
2018
Q2
$113K Buy
+10,200
New +$672K 0.04% 152

Other funds holding CVS

XR Securities's CVS Position: Q4 2021 in Review

XR Securities sold out of CVS Health (CVS) in Q4 2021, closing a stake of 2,837 shares — an estimated $241K sold.

XR Securities first reported a position in CVS in Q2 2018 and held it in 8 quarters. The position peaked at $762K in Q2 2018. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • XR Securities reported no remaining CVS Health position as of Q4 2021 after selling out during the quarter.
  • XR Securities sold 2,837 CVS Health shares in Q4 2021, an estimated $241K.
  • XR Securities first reported a position in CVS Health in Q2 2018 and held it in 8 quarters.
  • XR Securities's CVS Health position peaked at $762K in Q2 2018.
  • 2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on XR Securities's 13F filing for Q4 2021, filed 10 Jan 2022.